February 2020 - Page 8 of 19

ThursdayFeb 20, 2020 9:23 am

QualityStocksNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Prices $17,500,000 Common Stock Offering At-The-Market

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and other serious diseases, on Wednesday announced that it has entered into securities purchase agreements with institutional investors for the purchase and sale of 5,000,000 shares of common stock, par value $0.001 per share, at an offering price of $3.50 each, pursuant to a registered direct offering, priced at-the-market under Nasdaq rules. There are no warrants in the offering. The company intends to use the proceeds from the offering, which are anticipated to be roughly $17,500,000 before deducting fees and other estimated offering expenses,…

WednesdayFeb 19, 2020 11:41 am

Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary Advances Precision Therapeutics by Learning Cancer Behavior, Improving Outcomes

Predictive Oncology subsidiary TumorGenesis developing faster, less costly and more accurate PDx cancer models that better mimic patient’s tumor TumorGenesis revolutionary technology will provide pharmaceuticals with quicker, more effective drug development while significantly improving patient outcomes POAI to begin sales of TumorGenesis’ innovative culture media in the first half of 2020 TumorGenesis, a flagship subsidiary of Predictive Oncology Inc. (NASDAQ: POAI), has made concrete steps in identifying and separating cancer-related biomarkers, which is likely to speed the development of new and effective therapeutics. TumorGenesis media are specially formulated to help researchers isolate and maintain the unique histological and basic biological…

WednesdayFeb 19, 2020 10:43 am

Trxade Group Inc. (NASDAQ: MEDS) Uplists to Nasdaq, Expects Gross Proceeds of $5.2M from Common Stock Sale

Trxade announces pricing of a firm commitment public offering of 806,452 shares of its common stock Proceeds to be used as working capital and to fund future acquisitions Company’s B2B online purchasing platform currently has 11,900 pharmacies registered and is registering 100+ New pharmacies per month Trxade Group Inc. (NASDAQ: MEDS), an integrated drug delivery, procurement, and healthcare platform that offers healthcare buyers and sellers of pharmaceuticals increased profit margins, announced that its common stock has begun trading on the Nasdaq Capital Market under new ticker symbol ‘MEDS’, as of February 13, 2020. The company’s common stock will cease trading…

WednesdayFeb 19, 2020 10:04 am

QualityStocksNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Secures Cannabis Research License from Health Canada

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium, certified-organic cannabis, this morning announced that it has received a research license from Health Canada. The license is valid for five years and enables TGODF to cut the costs and quicken the pace of the development of new products by removing its need to rely on third parties. Looking forward, the company plans to leverage the license to carry out the development of additional premium cannabis 2.0 products, which are anticipated to launch later this year. “As consumers become increasingly aware that not all cannabis products…

WednesdayFeb 19, 2020 9:45 am

QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Closes Firm Commitment Common Stock Offering

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, on Tuesday announced the closing of its underwritten public offering of 806,452 shares of common stock at a price to the public of $6.50 each. The company granted the underwriters a 45-day option to obtain up to an additional 120,967 shares of common stock to cover any overallotments. Before the deduction of underwriting discounts and offering expenses, the company secured gross proceeds of $5.24 million from the offering, which it plans to utilize…

TuesdayFeb 18, 2020 2:11 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Founder & CEO Discusses Revolutionary BIGtoken Platform in Exclusive Interview

SRAX (NASDAQ: SRAX) founder and CEO Christopher Miglino recently discussed how the company’s proprietary BIGtoken platform has transformed consumer data collection during an exclusive interview at the LD Micro Main Event 2019. An article discussing the company reads, “With 16.4 million users worldwide, and three to five thousand new users joining each day, BIGtoken may be the most valuable opted-in data set in the world, said Miglino during the interview with SNN’s Robert Crafton (http://ibn.fm/LZQPh). Those numbers prove that consumers are looking for ways to receive compensation from marketers for using their data, said Miglino. Users worldwide can sign into…

TuesdayFeb 18, 2020 2:06 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Strikes Licensing Deal with Cannadips CBD

British Columbia-based Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) recently entered a definitive agreement to provide its patented DehydraTECH(TM) technology to Cannadips CBD. An article discussing the company reads, “The agreement announced recently provides Cannadips CBD with exclusive access rights to Lexaria’s technology for the U.S. market for 10 years, granting the ‘Original Smokeless CBD Dip Brand’ Lexaria’s fast-acting, high-absorption technology with options to expand the license to Europe, Mexico, and Canada and to renew the license for an additional five years (http://ibn.fm/8hoPO). . . . ‘This combination of superior science from Lexaria and a unique and strong branded proposition that…

TuesdayFeb 18, 2020 1:01 pm

SRAX Inc. (NASDAQ: SRAX) Reveals Strategic Plans for 2020 as Exclusive Platforms Start Generating Multiple Recurring Revenue Streams

SRAX CEO discusses company’s milestone achievements in 2019 Two flagship products – BIGtoken and SRAX IR – are generating multiple recurring revenue streams SRAX is strategically positioned for strong 2020 as proprietary products start contributing to the top line Company moves from development cycle to revenue cycle, anticipates 2020 growth In an exclusive interview with NNW’s Stuart Smith, SRAX Inc. (NASDAQ: SRAX) CEO Chris Miglino discusses the company’s milestone achievements in 2019 as well as its ambitious plans for 2020 to harness the brand recognition built on the emerging regulation underpinning consumer data protection (http://ibn.fm/G72dC). "That was a big year for…

TuesdayFeb 18, 2020 12:32 pm

Nightfood Holdings Inc.’s (NGTF) Better-For-You Ice Cream Now Being Recommended to Pregnant Women by Care Providers

Nightfood has superior nutritional profile for mothers-to-be Award-winning ice cream increasingly recommended to pregnant women by service providers. Nightfood aims to leverage untapped pregnancy market of up to 3 million women to accelerate national supermarket rollout Nightfood Holdings Inc. (OTCQB: NGTF) is changing the conversation around ice cream through its subsidiary Nightfood Inc., creator of an award-winning, nutrient-rich ice cream that is taking the pregnancy community by storm. With its unique and healthier nutritional profile, Nightfood is being recommended to pregnant women by their providers as a better option when pregnancy cravings inevitably hit. Nightfood is in position to dominate…

Site Search

Company Search

Month: February 2020